Skip to main content

MetLife Investment Management, LLC

Position in CCCC — C4 Therapeutics, Inc.

CIK 1529735 Whippany, NJ

Position in CCCC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$286,705
+$261,277 QoQ
Shares Held
61,393
+286.3% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 147 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CCCC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. CCCC ranks #164 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CCCC

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $286,705 61,393
2025-03-31 $25,428 15,893
2024-12-31 $103,874 28,854
2024-09-30 $202,093 35,455
2024-06-30 $71,503 15,477
2023-03-31 $86,271 27,475
2022-12-31 $162,102 27,475
2022-09-30 $240,955 27,475
2022-06-30 $159,184 21,112
2022-03-31 $512,177 21,112
2021-12-31 $428,904 13,320
2021-09-30 $595,137 13,320
2021-06-30 $504,028 13,320
2021-03-31 $197,822 5,348
2020-12-31 $177,179 5,348